Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lee Droemer

Pediatric Pulmonology Tulsa, OK Medical Doctor

NPI 1053511097 CMS profile 2411

6465 S Yale Ave Ste 910, Tulsa, OK 74136

Open in the dashboard

General payments

$6,924

438 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lee Droemer of Tulsa, OK is reported in the CMS Open Payments database as having received $6,924 across 438 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,048 65
2024 General $745 40
2023 General $676 38
2022 General $1,088 73
2021 General $1,407 100
2020 General $868 53
2019 General $1,093 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lee Droemer
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Lee Droemer were reported at $1,048. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Lee Droemer Pediatric Pulmonology median Middle half National median
2019 $1,093 $151 $59–$495 $163
2020 $868 $107 $34–$339 $114
2021 $1,407 $125 $40–$511 $132
2022 $1,088 $133 $49–$428 $149
2023 $676 $138 $44–$494 $160
2024 $745 $132 $46–$398 $164
2025 $1,048 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,421 94 payments
  2. Baxter Healthcare $913 42 payments
  3. Electromed, Inc. $794 59 payments
  4. AstraZeneca Pharmaceuticals LP $735 41 payments
  5. Chiesi USA, Inc. $621 59 payments
  6. Philips Electronics North America Corporation $480 27 payments
  7. Advanced Respiratory, Inc $372 27 payments
  8. Gilead Sciences, Inc. $225 13 payments
  9. Vertex Pharmaceuticals Incorporated $181 10 payments
  10. Covis Pharma B.V. $172 11 payments
  11. Other $1,009 55 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,657 396 payments
  2. Education $267 42 payments
Products named General payments · program years 2019–2025
  1. CREON $1,268 84 payments
  2. SMARTVEST $656 45 payments
  3. Hillrom - Monarch Airway Clearance System $529 23 payments
  4. PERTZYE $391 34 payments
  5. BEVESPI AEROSPHERE $384 21 payments
  6. SYMBICORT $356 17 payments
  7. Hillrom - Vest System Model 105 Home Care $325 15 payments
  8. BRONCHITOL $315 29 payments
  9. The Vest System Model 105 Home Care $280 22 payments
  10. BETHKIS $215 10 payments
  11. Other $2,639 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

438 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record